/THIS PRESS RELEASE IS BEING ISSUED IN CANADA ONLY AND MAY NOT BE
TRANSMITTED TO NEWS WIRE SERVICES IN THE UNITED STATES OR OTHERWISE
RELEASED IN THE UNITED STATES./
MONTREAL, Jan. 12 /CNW Telbec/ - Ranaz Corporation ("Ranaz") (TSX-V:
RNZ), a company specialized in the manufacturing and sale of protein and
dietary supplements, announces that it will proceed shortly with a
non-brokered private placement in the amount of US $550,000, or approximately
The private placement consists of the issuance of 4,920,258 units at
$0.135 per unit. Each unit consists of one share and half a warrant (for a
total of 2,460,129 warrants). Each whole warrant will entitle its holder to
purchase one share at $0.135 for a period of 24 months.
The proceeds of the private placement will be used for general corporate
The private placement, which is subject to the approval of the TSX
Venture Exchange, is expected to close on or about January 26, 2009.
This press release does not constitute an offer to sell or a solicitation
of an offer to purchase securities, nor an offer, solicitation or sale in any
jurisdiction where such offer may be unlawful.
About Ranaz Corporation
Ranaz is a corporation specializing in the manufacture and marketing of
protein and dietary supplements. Its mission is to design, develop and market
nutritional, protein and dietary supplements under its own corporate brands
and concepts, such as Protidiet and ProtiLife, as well as under private
labels. For more information about the Company, please visit our website at
Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond Ranaz's control.
Such risks include but are not limited to: the impact of general economic
conditions, changes in the regulatory environment in the jurisdictions in
which Ranaz does business, stock markets volatility, fluctuations in costs,
and changes to the competitive environment due to consolidation, as well as
other risks disclosed in public filings of Ranaz. Consequently, actual future
results may differ materially from the anticipated results expressed in the
forward-looking statements. The reader should not place undue reliance, if
any, on the forward-looking statements included in this news release. These
statements speak only as of the date made and Ranaz is under no obligation and
disavows any intention to update or revise such statements as a result of any
event, circumstances or otherwise.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
For further information:
For further information: Ranaz Corporation: Martin Vidal, Executive Vice
President and Chief Financial Officer, (450) 491-7106, Ext. 213,
firstname.lastname@example.org; SOLAK Communications: François Kalos, President,
(450) 993-0828, email@example.com